Effects of co-administration of the GABAB receptor agonist baclofen and a positive allosteric modulator of the GABAB receptor, CGP7930, on the development and expression of amphetamineinduced locomotor sensitization in rats

Pharmacological Reports

Volumn 65, Issue 5, 2013, Pages 1132-1143

  Cedillo, Laura N ^a   Miranda, Florencio ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Amphetamine; GABAB receptors; Sensitization

Indexed keywords

2,6 DI TERT BUTYL 4 (3 HYDROXY 2,2 DIMETHYLPROPYL)PHENOL; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; AMPHETAMINE; BACLOFEN;

ALLOSTERISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; LOCOMOTION; LOCOMOTOR SENSITIZATION; MALE; NEUROMODULATION; NONHUMAN; RAT;

AMPHETAMINE; ANIMALS; BACLOFEN; BEHAVIOR, ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GABA-B RECEPTOR AGONISTS; MALE; MOTOR ACTIVITY; PHENOLS; RATS; RATS, WISTAR; RECEPTORS, GABA-B;

EID: 84894186167     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71471-3     Document Type: Article

References (63)

1. Amara SG, Sonders MS: Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend, 1998, 51, 87-96. (Pubitemid 28353758)
2. Arnold JM, Roberts DCS: A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav, 1997, 57, 441-447. (Pubitemid 27296755)
3. Bartoletti M, Gubellini C, Ricci F, Gaiardi M: Baclofen blocks the development of sensitization to the locomotor stimulant effect of amphetamine. Behav Pharmacol, 2005, 16, 553-558. (Pubitemid 41416074)
4. Bartoletti M, Gubellini C, Ricci F, Gaiardi M: The GABAB agonist baclofen blocks the expression of sensitisation to the locomotor stimulant effect of amphetamine. Behav Pharmacol, 2004, 15, 397-401. (Pubitemid 39238353)
5. Bartoletti M, Ricci F, Gaiardi MA: GABAB agonist reverses the behavioral sensitization to morphine in rats. Psychopharmacology, 2007, 192, 79-85. (Pubitemid 46673894)
6. Binet V, Brajon C, Le Corre L, Acher F, Pin JP, Prezeau L: The heptahelical domain of GABAB2 is activated directly by CGP7930, a positive allosteric modulator of the GABAB receptor. J Biol Chem, 2004, 279, 29085-29091. (Pubitemid 38915779)
7. Bowery NG: GABAB receptor: A site of therapeutic benefit. Curr Opin Pharmacol, 2006, 6, 37-43. (Pubitemid 43103818)
8. Bowery NG, Hudson AL, Price GW: GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience, 1987, 20, 365-383. (Pubitemid 17048701)
9. Brebner K, Ahn S, Phillips AG: Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates. Psychopharmacology, 2005, 177, 409-417. (Pubitemid 40228287)
10. Brebner K, Froestl W, Andrews M, Phelan R, Roberts DCS: The GABAB agonist CGP 44532 decreases cocaine self-administration in rats: demonstration using a progressive ratio and a discrete trials procedure. Neuropharmacology, 1999, 38, 1797-1804. (Pubitemid 29430254)
11. Brebner K, Phelan R, Roberts DC: Effect of baclofen on cocaine self-administration in rats reinforced under fixed-ratio 1 and progressive-ratio schedules. Psychopharmacology, 2000, 148, 314-321. (Pubitemid 30136739)
12. Brebner K, Phelan R, Roberts DCS: Intra-VTA baclofen attenuates cocaine-self-administration on a progressive ratio schedule of reinforcement. Pharmacol Biochem Behav, 2000, 66, 857-862. (Pubitemid 30639483)
13. Broadbent J, Harless WE: Differential effects of GABAA and GABAB agonist on sensitization to the locomotor stimulant effects of ethanol in DBA/2J mice. Psychopharmacology (Berl), 1999, 197-205. (Pubitemid 29200172)
14. Chen Y, PhillipsK, Minton G, Sher E: GABAB receptor modulators potentiate baclofen-induced depression of dopamine neuron activity in the rat ventral tegmental area. Br J Pharmacol, 2005, 144, 926-932. (Pubitemid 40593018)
15. Colombo G, Serra S, Brunetti G, Atzori G, Pani M, Vacca G, Addolorato G et al.: The GABAB receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. Alcohol Alcohol, 2002, 37, 499-503.
16. Cryan JF, Kelly PH, Chaperon F, Gentsch C, Mombereau C, Lingenhoehl K, Froestl W: Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitropyrimidine- 4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines. J Pharmacol Exp Ther, 2004, 310, 952-963. (Pubitemid 39108915)
17. Di Chiara G: The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend, 1995, 38, 95-137.
18. Di Ciano P, Everitt BJ: The GABAB receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacology, 2003, 28, 510-518.
19. Fattore L, Cossu G, Martellotta MC, Fratta W: Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol Alcohol, 2002, 37, 495-498.
20. Filip M, Cunningham KA: Serotonin 5-HT2C receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine. Pharmacol Biochem Behav, 2002, 71, 745-756. (Pubitemid 34219225)
21. Filip M, Frankowska M: Effects of GABAB receptor agents on cocaine priming, discrete contextual cue and food induced relapses. Eur J Pharmacol, 2007, 571, 166-173. (Pubitemid 47385901)
22. Filip M, Frankowska M, Przegalinski E: Effects of GABAB receptor antagonist, agonists and allosteric positive modulator on the cocaine-induced self-administration and drug discrimination. Eur J Pharmacol, 2007, 574, 148-157. (Pubitemid 47575531)
23. Frankowska M, Nowak E, Filip M: Effects of GABAB receptor agonists on cocaine hyperlocomotor and sensitizing effects in rats. Pharmacol Rep, 2009, 61, 1042-1049.
24. Fu Z, Yang H, Xiao Y, Zhao G, Huang H:The gammaaminobutyric acid type B (GABAB) receptor agonist baclofen inhibits morphine sensitization by decreasing the dopamine level in rat nucleus accumbens Behav Brain Funct, 2012, 8, 20.
25. Hotsenpiller G, Wolf ME: Baclofen attenuates conditioned locomotion to cues associated with cocaine administration and stabilizes extracellular glutamate levels in the rat nucleus accumbens. Neuroscience, 2003, 118, 123-134. (Pubitemid 36369537)
26. Jacobson LH, Cryan JF: Differential sensitivity to the motor and hypothermic effects of the GABAB receptor agonist baclofen in various mouse strains. Psychopharmacology (Berl), 2005, 179, 688-699. (Pubitemid 40674771)
27. Johnson SW, North RA: Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol (Lond), 1992, 450, 455-468.
28. Kahlig KM, Galli A: Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine. Eur J Pharmacol, 2003, 479, 153-158. (Pubitemid 37377884)
29. Kalivas PW: Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev, 1993, 18, 75-113. (Pubitemid 23090012)
30. Kalivas PW, Duffy P, Eberhardt H: Modulation of A10 neurons by gamma-aminobutyric acid agonists. J Pharmacol Exp Ther, 1990, 253, 858-866. (Pubitemid 20181738)
31. Kalivas PW, Nakamura M: Neural systems for behavioral activation and reward. Curr Opin Neurobiol, 1999, 9, 223-227. (Pubitemid 29201796)
32. Kalivas PW, Stewart J: Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev, 1991, 223-244.
33. Kita H, Kitai ST: Glutamate descarboxylase immunoreactive neurons in the rat neostriatum: Their morphological types and population. Brain Res, 1988, 447, 346-352.
34. Koek W, France CP, Cheng K, Rice KC: Effects of the GABAB receptor-positive modulators CGP7930 and rac-BHFF in baclofen- and g-hydroxybutyrate- -discriminating pigeons. J Pharmacol Exp Ther, 2012, 341, 369-376.
35. Koob GF: Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci, 1992, 13, 177-184.
36. Koob GF, Bloom FE: Cellular and molecular mechanisms of drug dependence. Science, 1988, 242, 715-723.
37. Kruse LC, Linsenbardt DN, Boehm II SL: Positive allosteric modulation of the GABAB receptor by GS39783 attenuates the locomotor stimulant actions of ethanol and potentiates the induction of locomotor sensitization. Alcohol, 2012, 46, 455-462.
38. Lhuillier L, Mombereau C, Cryan JF, Kaupmann K: GABAB receptor positive modulation decreases selective molecular and behavioral effects of cocaine. Neuropsychopharmacology, 2007, 32, 388-398. (Pubitemid 46106945)
39. Liang JH, Chen F, Krstew E, Cowen MS, Carroll FY, Crawford D, Beart PM, Lawrence AJ: The GABAB receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcoholpreferring rats. Neuropharmacology, 2006, 50, 632-639.
40. Lobina C, Carai MA, Froestl W, Mugnaini C, Pasquini S, Corelli F, Gessa GL, Colombo G: Activation of the GABAB receptor prevents nicotine-induced locomotor stimulation in mice. Front Psychiatry, 2011, 2, 1-5.
41. Miranda F, Jiménez JC, Cedillo LN, Sandoval-Sánchez A, Millán-Mejía P, Sánchez-Castillo H, Velázquez- Martínez DN: The GABA-B antagonist 2-hydroxysaclofen reverses the effect of baclofen on the discrimi- native stimulus effects of d-amphetamine in the conditioned taste aversion procedure. Pharmacol Biochem Behav, 2009, 93, 25-30.
42. Nagai T, McGeer PL, McGeer EG: Distribution of GABA-T-intensive neurons in the rat forebrain and midbrain. J Comp Neurol, 1983, 218, 220-238. (Pubitemid 13035079)
43. Orrù A, Lai P, Lobina C, Maccioni P, Piras P, Scanu L, Froestl W et al.: Reducing effect of the positive allosteric modulators of the GABAB receptor, CGP7930 and GS39783, on alcohol intake in alcohol-preferring rats. Eur J Pharmacol, 2005, 525, 105-111. (Pubitemid 41689029)
44. Paterson NE, Froestl W, Markou A: The GABAB receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat. Psychopharmacology (Berl), 2004, 172, 179-186. (Pubitemid 38388767)
45. Paterson NE, Vlachou S, Guery S, Kaupmann K, Froestl W, Markou A: Positive modulation of GABAB receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. J Pharmacol Exp Ther, 2008, 326, 306-314. (Pubitemid 351872150)
46. Pierce RC, Kalivas PW: A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res, 1997, 25, 192-216. (Pubitemid 27501800)
47. Pin JP, Kniazeff J, Binet V, Liu J, Maurel D, Galvez T, Duthey B et al.: Activation mechanisms of the heterodimeric GABAB receptor. Biochem Pharmacol, 2004, 68, 1565-1572. (Pubitemid 39286461)
48. Ranaldi R, Poeggel K: Baclofen decreases methamphetamine self-administration in rats. Neuro Report, 2002, 13, 1107-1110. (Pubitemid 34722034)
49. Roberts DCS, Andrews MM: Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure. Psychopharmacology, 1997, 131, 271-277. (Pubitemid 27283589)
50. Roberts DCS, Brebner K: GABA modulation of cocaine self-administration. Ann N Y Acad Sci, 2000, 909, 145-158. (Pubitemid 30462037)
51. Robinson TE, Berridge KC: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev, 1993, 18, 247-291. (Pubitemid 23219500)
52. Rothman RB, Baumann MH: Monoamine transporters and psychostimulant drugs. Eur J Pharmacol, 2003, 479, 23-40. (Pubitemid 37377873)
53. Shoaib M, Swanner LS, Beyer CE, Golberg SR, Schindler CW: The GABAB agonist baclofen modifies cocaine self-administration in rats. Behav Pharmacol, 1998, 9, 195-206. (Pubitemid 28273107)
54. Smith MA, Yancey DL, Morgan D, Liu Y, Froestl W, Roberts DC: Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats. Psychopharmacology (Berl), 2004, 173, 105-111. (Pubitemid 38591153)
55. Sugita S, Johnson SW, North RA: Synaptic inputs to GABAA and GABAB receptors originate from discrete afferent neurons. Neurosci Lett, 1992, 134, 207-211.
56. Urwyler S, Mosbacher J, Lingenhoehl K, Heid J, Hofstetter K, Froestl W, Bettler B, Kaupmann K: Positive allosteric modulation of native and recombinant gamma-aminobutyric acidB receptors by 2,6-di-tertbutyl- 4-(3-hydroxy-2,2- dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501. Mol Pharmacol, 2001, 60, 963-971. (Pubitemid 33027431)
57. Urwyler S, Pozza MF, Lingenhoehl K, Mosbacher J, Lampert C, Froestl W, Koller M, Kaupmann K: N,NDicyclopentyl- 2-methylsulfanyl-5-nitro-pyrimidine-4,6- diamine (GS39783) and structurally related compounds: novel allosteric enhancers of g-aminobutyric acidB receptor function. J Pharmacol Exp Ther, 2003, 307, 322-330.
58. Vezina P, Leyton M: Conditioned cues and the expression of stimulant sensitization in animals and humans. Neuropharmacology, 2009, 56, 160-168.
59. Westerink B H, Kwint HF, De Vries J B: The pharmacology of mesolimbic dopamine neurons: A dual probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J. Neurosci, 1996, 16, 2605-2611. (Pubitemid 26124349)
60. Wiley JL, Evans RL, Grainger DB, Nicholson KL: Locomotor activity changes in female adolescent and adult rats during repeated treatment with a cannabinoid or club drug. Pharmacol Rep, 2011, 63, 1085-1092.
61. Xi ZX, Stein EA: Baclofen inhibits heroin selfadministration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther, 1999, 290, 1369-1374. (Pubitemid 29400282)
62. Yoshida M, Yokoo H, Tanaka T, Emoto H, Tanaka M: Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat. Brain Res, 1994, 636, 111-114. (Pubitemid 24035698)
63. Zancheta R, Possi APM, Planeta CS, Marin MT: Repeated administration of caffeine induces either sensitization or tolerance of locomotor stimulation depending on the environmental context. Pharmacol Rep, 2012, 64, 1734-1140.